Foremost aims to commercialize a technology that can convert dairy manufacturing co-products into environmentally friendly, value-added materials The partners aim to reduce the dairy industry's carbon ...
We live in the age of the elevator pitch, catchy soundbites, and companies promising to revolutionize every industry under the sun. No other field attracts more visionaries than healthcare. After all, ...
Ginkgo Bioworks focuses on its Foundry and Code Base assets to offer R&D services and drive down costs for clients. The company secures a significant deal with Pfizer in the drug discovery category, ...
The MarketWatch News Department was not involved in the creation of this content. Leiden, The Netherlands -- 11 December 2025 -- ProteoNic BV, a leading provider of premium vector technology for ...
The Ginkgo Technology Network brings together over 25 diverse partners across an array of capabilities including AI, genetic medicines, biologics, and manufacturing. As a Ginkgo Technology Network ...
Jason Kelly, CEO of Ginkgo Bioworks: "I'm excited to see how the community builds on top of these models and our API. AA-0 is the first model we have released trained on Ginkgo's proprietary data – we ...
Leiden, The Netherlands – 11 December 2025 – ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback